AI Verdict
IDXX has stronger fundamentals based on our AI analysis.
IDXX vs REGN Fundamental Comparison
| Metric | IDXX | REGN |
|---|---|---|
| Revenue | $1.1B | $3.6B |
| Net Income | $278.4M | $727.2M |
| Net Margin | 24.4% | 20.2% |
| ROE | 17.9% | 2.3% |
| ROA | 8.2% | 1.8% |
| Current Ratio | 1.12x | 3.57x |
| Debt/Equity | 0.19x | 0.06x |
| EPS | $3.47 | $6.75 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IDXX vs REGN: Frequently Asked Questions
Is IDXX or REGN the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IDXX has stronger fundamentals. IDXX is graded A+ (82% confidence) while REGN is graded A (80% confidence). This is not investment advice.
How does IDXX compare to REGN fundamentally?
IDEXX LABORATORIES INC /DE has ROE of 17.9% vs REGENERON PHARMACEUTICALS, INC.'s 2.3%. Net margins are 24.4% vs 20.2% respectively.
Which stock pays higher dividends, IDXX or REGN?
IDXX has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IDXX or REGN for long term?
For long-term investing, consider that IDXX has a A+ grade with 82% confidence, while REGN has a A grade with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IDXX vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IDXX vs REGN, the AI consensus favors IDXX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.